10x Genomics Inc - Class A

Market cap: $15,991,175,122

Sector: NAS

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company?s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.

Key Statistics

Company Name

10x Genomics Inc

Average Volume (10 days)

667,975

Average Volume (30 days)

841,770

Moving Average (50 days)

$172.44

Moving Average (200 days)

$155.62

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

0

Market Cap

15,991,175,122

Shares Outstanding

86,071,237

52-Week High Split Adjust Only

201.7

52-Week Low Split Adjust Only

58.04

Employee Count

500

Beta

0.8756

Next Earnings Date

2021-05-10

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.12%

Past 30 days

-0.01%

Past 3 months

0.31%

Past 6 months

0.47%

Past year

2.18%

Past 2 years

2.52%

Past 5 years

2.52%

Max % Change

2.52%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
10x Genomics Inc - Class ATXGn/an/a-203.8n/an/a
Peer AvgN/A16.078.58-1.616.0715.25
Outlook Therapeutics IncOTLK64.2934.32-6.464.2961.00
Organovo Holdings IncONVOn/an/an/an/an/a